Atypical Hemolytic Uremic Syndrome market

Atypical Hemolytic Uremic Syndrome (aHUS) is a chronic, ultra-rare disease characterized by thrombotic microangiopathy (TMA), the formation of blood clots in small blood vessels throughout the body, causing a reduction in platelet count and life-threatening damage to the kidney, brain, heart and other vital organs. DelveInsight’s Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market ForecastContinue reading “Atypical Hemolytic Uremic Syndrome therapeutic market by Delveinsight”